Literature DB >> 15664906

Oral mucosal endotoxin tolerance induction in chronic periodontitis.

Manoj Muthukuru1, Ravi Jotwani, Christopher W Cutler.   

Abstract

The oral mucosa is exposed to a high density and diversity of gram-positive and gram-negative bacteria, but very little is known about how immune homeostasis is maintained in this environment, particularly in the inflammatory disease chronic periodontitis (CP). The cells of the innate immune response recognize bacterial structures via the Toll-like receptors (TLR). This activates intracellular signaling and transcription of proteins essential for the induction of an adaptive immune response; however, if unregulated, it can lead to destructive inflammatory responses. Using single-immunoenzyme labeling, we show that the human oral mucosa (gingiva) is infiltrated by large numbers of TLR2(+) and TLR4(+) cells and that their numbers increase significantly in CP, relative to health (P < 0.05, Student's t test). We also show that the numbers of TLR2(+) but not TLR4(+) cells increase linearly with inflammation (r(2) = 0.33, P < 0.05). Double-immunofluorescence analysis confirms that TLR2 is coexpressed by monocytes (MC)/macrophages (mphi) in situ. Further analysis of gingival tissues by quantitative real-time PCR, however, indicates that despite a threefold increase in the expression of interleukin-1beta (IL-1beta) mRNA during CP, there is significant (30-fold) downregulation of TLR2 mRNA (P < 0.05, Student's t test). Also showing similar trends are the levels of TLR4 (ninefold reduction), TLR5 (twofold reduction), and MD-2 (sevenfold reduction) mRNA in CP patients compared to healthy persons, while the level of CD14 was unchanged. In vitro studies with human MC indicate that MC respond to an initial stimulus of lipopolysaccharide (LPS) from Porphyromonas gingivalis (PgLPS) or Escherichia coli (EcLPS) by upregulation of TLR2 and TLR4 mRNA and protein; moreover, IL-1beta mRNA is induced and tumor necrosis factor alpha (TNF-alpha), IL-10, IL-6, and IL-8 proteins are secreted. However, restimulation of MC with either PgLPS or EcLPS downregulates TLR2 and TLR4 mRNA and protein and IL-1beta mRNA and induces a ca. 10-fold reduction in TNF-alpha secretion, suggesting the induction of endotoxin tolerance by either LPS. Less susceptible to tolerance than TNF-alpha were IL-6, IL-10, and IL-8. These studies suggest that certain components of the innate oral mucosal immune response, most notably TLRs and inflammatory cytokines, may become tolerized during sustained exposure to bacterial structures such as LPS and that this may be one mechanism used in the oral mucosa to attempt to regulate local immune responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664906      PMCID: PMC547058          DOI: 10.1128/IAI.73.2.687-694.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2.

Authors:  H Y Song; C H Régnier; C J Kirschning; D V Goeddel; M Rothe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 2.  The Toll-like receptors and their role in septic shock.

Authors:  Patricia Cristofaro; Steven M Opal
Journal:  Expert Opin Ther Targets       Date:  2003-10       Impact factor: 6.902

3.  Interleukin-1 beta and tumor necrosis factor-alpha stimulate synergistically the expression of monocyte chemoattractant protein-1 in fibroblastic cells derived from human periodontal ligament.

Authors:  K Ozaki; S Hanazawa; A Takeshita; Y Chen; A Watanabe; K Nishida; Y Miyata; S Kitano
Journal:  Oral Microbiol Immunol       Date:  1996-04

4.  Fimbriated Porphyromonas gingivalis is more efficient than fimbria-deficient P. gingivalis in entering human dendritic cells in vitro and induces an inflammatory Th1 effector response.

Authors:  Ravi Jotwani; Christopher W Cutler
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

5.  Induction of tolerance by Porphyromonas gingivalis on APCS: a mechanism implicated in periodontal infection.

Authors:  N Cohen; J Morisset; D Emilie
Journal:  J Dent Res       Date:  2004-05       Impact factor: 6.116

6.  Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro.

Authors:  Ravi Jotwani; Bali Pulendran; Sudhanshu Agrawal; Christopher W Cutler
Journal:  Eur J Immunol       Date:  2003-11       Impact factor: 5.532

7.  Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells.

Authors:  Stephen R Coats; Robert A Reife; Brian W Bainbridge; T Thu-Thao Pham; Richard P Darveau
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  Calprotectin release from human neutrophils is induced by Porphyromonas gingivalis lipopolysaccharide via the CD-14-Toll-like receptor-nuclear factor kappaB pathway.

Authors:  Jun-ichi Kido; Reiko Kido; Masatoshi Kataoka; Magne K Fagerhol; Toshihiko Nagata
Journal:  J Periodontal Res       Date:  2003-12       Impact factor: 4.419

9.  Genetic structure of populations of Porphyromonas gingivalis associated with periodontitis and other oral infections.

Authors:  B G Loos; D W Dyer; T S Whittam; R K Selander
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

10.  Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity.

Authors:  D L Fraker; M C Stovroff; M J Merino; J A Norton
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  50 in total

Review 1.  Dendritic cells at the oral mucosal interface.

Authors:  C W Cutler; R Jotwani
Journal:  J Dent Res       Date:  2006-08       Impact factor: 6.116

2.  Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection.

Authors:  R Wadachi; K M Hargreaves
Journal:  J Dent Res       Date:  2006-01       Impact factor: 6.116

3.  Antigen capture of Porphyromonas gingivalis by human macrophages is enhanced but killing and antigen presentation are reduced by endotoxin tolerance.

Authors:  Manoj Muthukuru; Christopher W Cutler
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

Review 4.  Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists.

Authors:  Christopher W Cutler; Yen-Tung A Teng
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

Review 5.  Immune cells link obesity-associated type 2 diabetes and periodontitis.

Authors:  M Zhu; B S Nikolajczyk
Journal:  J Dent Res       Date:  2014-01-06       Impact factor: 6.116

Review 6.  Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.

Authors:  Jennifer L Krauss; Jan Potempa; John D Lambris; George Hajishengallis
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

7.  Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production.

Authors:  Takashi Ukai; Hiromichi Yumoto; Frank C Gibson; Caroline Attardo Genco
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

8.  A novel class of lipoprotein lipase-sensitive molecules mediates Toll-like receptor 2 activation by Porphyromonas gingivalis.

Authors:  Sumita Jain; Stephen R Coats; Ana M Chang; Richard P Darveau
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

9.  Signaling mechanism for Aspergillus fumigatus tolerance in corneal fibroblasts induced by LPS pretreatment.

Authors:  Leyi Wang; Hongling Yang; Yuan Sun; Fu-Shin X Yu; Xinyi Wu
Journal:  Innate Immun       Date:  2013-09-17       Impact factor: 2.680

Review 10.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.